Caitlyn Thomas

Ms. Caitlyn Thomas

Department of Chemistry and Biochemistry, Miami University, Oxford, OH 45056, USA

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 March 2020 in Biomolecules
Verified
Journal Article
Open access
PDF file
ZCZishuo Cheng
Zishuo Cheng
CTCaitlyn Thomas
Caitlyn Thomas
AJAdam R. Joyner
Adam R. Joyner
RKRobert L. Kimble
Robert L. Kimble
ASAidan Sturgill
Aidan Sturgill
MCMichael Crowder
Michael Crowder
In an effort to facilitate the discovery of new, improved inhibitors of the metallo-β-lactamases (MBLs), a new, interactive website called MBLinhibitors.com was developed. Despite considerable efforts from the science community, there are no clinical inhibitors of the MBLs, which are now produced by human pathogens. The website, MBLinhibitors.com, contains a searchable database of known MBL inhibitors, and inhibitors can be searched by chemical name, chemical formula, chemical structure, Simplified Molecular-Input Line-Entry System (SMILES) format, and by the MBL on which studies were conducted. The site will also highlight a “MBL Inhibitor of the Month”, and researchers are invited to submit compounds for this feature. Importantly, MBLinhibitors.com was designed to encourage collaboration, and researchers are invited to submit their new compounds, using the “Submit” function on the site, as well as their expertise using the “Collaboration” function. The intention is for this site to be interactive, and the site will be improved in the future as researchers use the site and suggest improvements. It is hoped that MBLinhibitors.com will serve as the one-stop site for any important information on MBL inhibitors and will aid in the discovery of a clinically useful MBL inhibitor.

28 October 2023 in Microorganisms
Verified
Journal Article
Open access
PDF file
BBBogdan M. Benin
Bogdan M. Benin
THTrae Hillyer
Trae Hillyer
ACAylin S. Crugnale
Aylin S. Crugnale
AFAndrew Fulk
Andrew Fulk
CTCaitlyn Thomas
Caitlyn Thomas
WSWoo Shik Shin
Woo Shik Shin
Among the various mechanisms that bacteria use to develop antibiotic resistance, the multiple expression of β-lactamases is particularly problematic, threatening public health and increasing patient mortality rates. Even if a combination therapy—in which a β-lactamase inhibitor is administered together with a β-lactam antibiotic—has proven effective against serine-β-lactamases, there are no currently approved metallo-β-lactamase inhibitors. Herein, we demonstrate that quercetin and its analogs are promising starting points for the further development of safe and effective metallo-β-lactamase inhibitors. Through a combined computational and in vitro approach, taxifolin was found to inhibit VIM-2 expressing P. aeruginosa cell proliferation at <4 μg/mL as part of a triple combination with amoxicillin and clavulanate. Furthermore, we tested this combination in mice with abrasive skin infections. Together, these results demonstrate that flavonol compounds, such as taxifolin, may be developed into effective metallo-β-lactamase inhibitors.